Prof. Dr. Meral Mert
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Diabetes Mellitus, Type 2 11 publicationsSource: OpenAlex / PubMed MeSHView publications
- Pituitary Neoplasms 4 publications
- Diabetes Mellitus, Type 1 3 publications
- Thyroid Neoplasms 3 publications
- Obesity 3 publications
- Adenoma 3 publications
- Weight Gain 2 publications
- Weight Loss 2 publications
- Osteoporosis 2 publications
- COVID-19 2 publications
- Acromegaly 2 publications
- Prolactinoma 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyEndocrinology and Metabolic Diseasessaglik.gov.trFrom source
- Department name at the sourceEndokrinolojisaglik.gov.trFrom source
- InstitutionBakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Area of workDiabetes Mellitus, Type 2Extracted from 11 publications · Model version —From source
- Publications182 publicationsORCID, OpenAlexFrom source
- ORCID0000-0003-3431-0915ORCIDFrom source
- Last synchronised5 November 2026 08:55https://bakirkoysadikonukeah.saglik.gov.tr/TR-1482111/doktorlarimiz.html#meral-mertsaglik.gov.tr
Scientific work
Publications on Diabetes Mellitus, Type 2
-
Genetic spectrum and genotype–phenotype associations in Paget's disease of bone: A nationwide multicenter study from Türkiye
Bone, 2027
DOI 10.1016/j.bone.2026.118134 PMID 42887663 Source: ORCID
-
Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study)
Journal of Diabetes and its Complications, 2026
DOI 10.1016/j.jdiacomp.2026.109348 PMID 42413349 Open-access full textSource: OpenAlex
-
Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry
Cardiovascular Drugs and Therapy, 2026
DOI 10.1007/s10557-026-07944-w PMID 42720721 1 citation (OpenAlex) Open-access full textSource: OpenAlex
-
Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study
BMC Nephrology, 2026
DOI 10.1186/s12882-026-05259-4 PMID 42693414 1 citation (OpenAlex) Open-access full textSource: OpenAlex
-
Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort
Clinical Kidney Journal, 2026
DOI 10.1093/ckj/sfag227 PMID 42592375 Open-access full textSource: OpenAlex
-
Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15155758 PMID 42589862 Open-access full textSource: OpenAlex
-
Long-Term Outcomes and Predictors of Recurrent Weight Gain After Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and One Anastomosis Gastric Bypass: Turkish Metabolic and Bariatric Surgery Follow-up Study (TMBS Study)
Obesity Surgery, 2026
DOI 10.1007/s11695-026-08927-4 PMID 42803907 Source: ORCID
-
The relationship between triglyceride-glucose index and lipid profile, hormonal, and biochemical parameters in patients with polycystic ovary syndrome
Exploration of Endocrine and Metabolic Diseases, 2026
DOI 10.37349/eemd.2026.101479 Open-access full textSource: ORCID
-
Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy
Endocrine Connections, 2026
DOI 10.1530/ec-26-0103 PMID 42447041 Open-access full textSource: OpenAlex
-
P-076 A RARE CASE OF HIV PRESENTING WITH PRIMARY PITUITARY LYMPHOMA
JCEM Case Reports, 2026
DOI 10.1210/jcemcr/luaf297.062 Open-access full textSource: OpenAlex